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Purpose: Findings from the Asymptomatic Carotid Atherosclerosis Study (ACAS) indicate 
that carotid endarterectomy can be beneficial in symptom-free patients with 60% to 99% 
carotid artery stenosis. However, patients in ACAS who underwent contrast angiography 
(CA) before carotid endarterectomy were exposed to an additional 1.2% risk of stroke. 
Methods: We used the methods of decision analysis to assess whether the overall 5-year 
stroke risk in symptom-free patients with suspected carotid artery disease can be reduced 
by preoperative imaging with magnetic resonance angiography (MRA) or duplex 
ultrasonography (DU). We compared four strategies for the preoperative evaluation of 
carotid artery stenosis in symptom-free patients: 1) CA alone, 2) MRA alone, 3) DU alone, 
and 4) MRA and DU with CA when the results of these tests disagree. Accuracies of MRA 
and DU were estimated from 81 patients exposed to all three procedures; stroke risks for 
patients with 60% to 99% carotid artery stenosis were obtained from ACAS. 
Results: For predicting 60% to 99o/0 carotid stenoses, sensitivity and specificity for 
noninvasive t sts, optimized to reduce morbidity, were as follows: DU (0.96, 0.66), MRA 
(1.00, 0.7ö), DU/MRA (1.00, 0.86; 26% would require CA). The 5-year stroke risk of 
these four strategies in order of decreasing benefit was MRA, 6.17%; MRA/DU, 6.34%; 
DU, 6.35%; and CA, 7.12%. In sensidvity analyses, noninvasive tests were advantageous 
even if the stroke rate with CA diminished to 0.4%, or if the sensitivity and specificity of 
noninvasive t sts fell to 70%. 
Conclusion: The preoperative use of noninvasive t sts resulted in a lower 5-year stroke risk 
compared with CA in symptom-free patients with suspected carotid artery stenosis. 
(J VASC SIJRG 1995;22:706-16.) 
Early results from the Asymptomatic Carotid 
Atherosclerosis Study (ACAS) have recently been 
reported.1 In this study, symptom-free patients with 
60% to 99% carotid artery stenosis were randomized 
to receive either carotid endarterectomy or medical 
therapy. With primary end points of ipsilateral stroke 
or any stroke or death occurring in the perioperative 
period, ACAS showed a 55% relative risk reduction 
for carotid endarterectomy compared with medical 
therapy. 
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A variety of imaging smdies are available to 
quantify the degree of stenosis in patients with 
suspected carotid artery disease. Contrast angiogra- 
phy (CA) is the traditional method for evaluating the 
carotid bifurcation before carotid endarterectomy 
and is considered the gold standard; however, it is 
associated with an immediate risk of stroke. For this 
reason many centers advocate the use of noninvasive 
tests for the preoperative evaluation of the carotid 
bifurcation. 2-6 Although reasonable accuracies for 
duplex ultrasonography (DU) and magnetic reso- 
nance angiography (MRA) have been reported, 7la 
little consideration has been given m the long-term 
consequences of a misdiagnosis resulting from these 
tests. For example, if a symptom-free patient with a 
60% to 99% stenosis is classified by DU as having a 
low-grade stenosis and thus does not undergo carotid 
endarterectomy, he or she would incur an additional 
risk of stroke of 5.5% over the ensuing 5 years, 
according to ACAS results. 
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We used the methods of decision analysis z4 to 
combine the results from ACAS with data from other 
sources to evaluate the relative benefit of four preop- 
erative imaging strategies for the detection of 60% to 
99% carotid artery stenosis in patients without symp- 
toms. We sought o identify the diagnostic strategy 
that minimized 5-year morbidity; this investigation 
involved weighing the long-term benefits and risks of 
an accurate test, which has immediate risk (CA), 
against less accurate tests uch as DU or MRA, which 
have no immediate risk but which may result in in- 
creased morbidity over the long term. Similar model- 
ing techniques have been successfully used to deter- 
mine the clinical indications for diagnostic evaluation 
of carotid artery disease 15 and for carotid endarter- 
ectomy. 16 
METHODS 
Model for comparison of preoperative strategies 
We estimated the 5-year morbidity rate associated 
with four strategies for the preoperative evaluation of 
symptom-free patients with suspected carotid artery 
disease. These included DU, MRA, CA, and the 
combination of DU and MRA followed by CA for 
disparate results (herein referred to as the combina- 
tion strategy). 17~8 For the three strategies that 
involved noninvasive testing, we considered a num- 
ber of different definitions for a positive test result, 
where each definition resulted in a unique sensitivity 
and specificity. 
We estimated the percentage of patients within 
each alternative who would have development of an 
ipsilateral stroke over the ensuing 5 years, including 
all strokes and deaths in the perioperative period and 
strokes caused by CA. We assumed that all patients 
with a positive noninvasive test result (indicating 
60% to 99% carotid artery stenosis) would undergo 
carotid endarterectomy and estimated the 5-year 
stroke risk that would follow a true- and false-positive 
study result, as well as a true- and false-negative study. 
For the three strategies that involved noninvasive 
testing, we estimated the 5-year isk for each possible 
sensitivity and specificity pair. Because many centers 
may not have adequate MR_A, we subsequently 
compared the morbidity rate of DU with that of CA. 
Diagnostic accuracies for DU and MRA and their 
combination were estimated from data collected on 
81 patients studied prospectively with all three 
techniques. Morbidity and mortality estimates were 
obtained from ACAS when feasible and from the 
literature, otherwise. Sensitivity analyses were per- 
formed to determine the sensitivity of the baseline 
results to variations in the model parameters. Analy- 
ses were performed with SMLTREE software, ver- 
sion 2.9 (James Hollenberg, MD, Roslyn, N.Y.). 
Data and assumptions 
Over a 19-month period, 81 patients at Beth 
Israel Hospital (J.J.S., K.C.K.) and Brigham and 
Women's Hospital (A.D.W.) referred for CA were 
entered into the study. We excluded patients who had 
contraindications to or refused MRA. Patients un- 
derwent DU before their referral and were subse- 
quently studied with MRA and CA. The average age 
was 70 (range 48 to 87). There were 58 men and 30 
women. The clinical presentation was consistent with 
atherosclerotic occlusive disease in all cases, and 
patients who had CA for other indications were 
excluded. Seventy-four arteries had produced symp- 
toms (transient ischemic attack in 24, amaurosis 
fugax in 29, stroke in 21), and 102 arteries were 
asymptomatic. Of the 162 arteries, images of 158 
were obtained by CA, 157 by MRA, 160 by DU, and 
151 by all three techniques. We based our analyis on 
the 151 arteries that underwent all three modafities. 
Digital subtraction arteriograms, including at 
least two views of the carotid bifurcation and intra- 
cranial vessels, were blindly reviewed by two inde- 
pendent observers. Images were uniformly overhead- 
projected, traced, and measured with digital calipers 
(Fowler, Newton, Mass.). Tile maximum percent re- 
ductions in diameter of both the extracranial and 
intracranial carotid arteries were determined by the 
formula percent stenosis = (1 -  Dston/D . . . .  ) x 
100, where D~to n is the diameter of the carotid artery 
at the point of greatest stenosis and D . . . .  is the 
diameter of the nondiseased distal internal carotid 
artery. We used the angiographic measurements from 
one reviewer for our analysis and checked the reliabil- 
ity of this assignment with readings from the second 
reviewer (kappa = 0.93). 
MRA evaluation was performed at the Beth Israel 
Hospital for all patients with a three-dimensional 
time-of-flight technique and additional information 
was obtained from two-dimensional time-of-flight 
and source images. 19 The percent stenosis was 
determined in the same manner as CA by two 
independent observers who were different from the 
readers for CA. Data for our analysis were obtained 
from one reader, and measurements from the second 
reviewer were used to assess reliability with the kappa 
statistic (kappa -- 0.88). 
Doppler ultrasonography was performed at the 
Beth Israel Hospital, the Brigham and Women's 
Hospital, or in other certified laboratories (41, 32, 
and 8 patients, respectively). Techniques were stan- 
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Table I. Short- and long-term probabilities of stroke for symptom-free patients with suspected 
carotid artery stenosis* 
Carotid arrery stenosis 
Carotid endarterectomy 214edical therapy 
0%-59% (FP) 60%-99% (TP) 100% (FP) 0%-59% (TN) 60%-99% (FN) 100% (TN) 
30-day risk of any stroke or 
dcath 
With CA na 2.7 na na na na 
Without CA 1.5 1.5 1.2t na na na 
30-day to 5-year risk of ip- 2.9 2.9 24.3 na na na 
silateral stroke:~ 
5-year risk§ 
With CA na 5.5 na 4.1 na 25.5 
Without CA 4.3 4.3 25.2 2.9 10.6 24.6 
FP, False-positive; TP, true-positive; TN, true-negative; FN, false-negative. 
*Values are percentages and may not reflect reported ACAS results, which are based on an intention to treat analysis. 
tlncludes urgical risk (50% that of nonocclusive disease) and 30-day risk of  stroke with occlusive disease. 
$Conditional on being stroke-free at 30 days. 
§Numbers are not additive because 30-day to 5-year risk of ipsilateral stroke is conditional on being stroke-free at 30 days. 
dardized between the Beth Israel and Brigham and 
Women's Hospitals, and the technique used for DU 
from the other laboratories were evaluated for 
uniformity before data were included in this study. 
Peak and end-diastolic velocities for the common and 
internal carotid arteries were measured. A markedly 
diminished velocity implied high-grade stenosis, and 
the absence of flow implied occlusion. 
Receiver operating characteristic curves 2° were 
constructed by varying the positivity criteria for 
detecting a 60% to 99% stenosis of the carotid artery 
as determined by CA. For purposes of calculating 
sensitivities and specificities, nonsurgical categories 
of disease were grouped together; for example, 
low-grade stenoses (0% to 59%) were grouped with 
occlusions. To simplify calculations and aid in 
interpretation, we used four definitions of a positive 
test result for MRA: (1) signal void or 50% to 99% 
stenosis, (2) signal void or 60% to 99% stenosis, (3) 
signal void or 70% to 99% stenosis, and (4) signal 
void or 80% to 99% stenosis. A signal void, although 
not quantifiable, is known to represent a severe 
stenosis. For DU, we used four definitions of a 
positive test result for DU on the basis of the peak 
systolic velocity of the internal carotid artery: (1) 
markedly diminished velocity or 150 cm/sec or 
greater, (2) markedly diminished velocity or 200 
cm/sec or greater, (3) markedly dirninished velocity 
or 250 cm/sec or greater, and (4) markedly dimin- 
ished velocity or 300 cm/sec or greater. 
For the combination strategy, we considered all 
16 permutations of the above definitions for &sig- 
nating a test result positive and calculated sensitivities 
and specificities conditional on the test results being 
in agreement. In addition to these diagnostic mea- 
sures, the proportion of patients who ultimately 
undergo CA (with its associated risk) as a result of 
disparate test results was estimated. 
For the hypothetical patient undergoing carotid 
endarterectomy in our analysis, we separated the time 
after preoperative imaging into an initial 30-day 
period (operative and angiographic risk) and a 
30-day to 5-year period (long-term risk). In ACAS, 
1.5% of those patients who had carotid endarterec- 
tomy and 1.2% of those who underwent CA had a 
stroke or died (personal communication, James F. 
Toole, MD, April 20, 1995). Excluding the risk as a 
result of CA, the overall 5-year isk was 4.3% and 
10.6% for patients treated surgically and medically, 
respectively. We assumed that the operative risk of 
paraents with occlusions who inappropriately un- 
dergo carotid endarterectomy was 50% that of 
patients with nonocclusive disease. Long-term stroke 
risks (after 30 days) for patients with 0% to 59% 
stenosis, treated either medically or surgicaUy, were 
assumed to be the same as those patients who had 
undergone carotid endarterectomy for high-grade 
stenoses. For occlusions, we used a 5.5% annual 
probability of stroke. 2~ We estimated that 45% of 
symptom-free patients with suspected carotid artery 
stenosis would have 60% to 99% angiographic 
stenosis. 22 Baseline stimates of the risks ofstroke are 
given in Table I. 
Our analysis was based on the premise that all 
patients with suspected carotid artery stenosis were 
initially screened with DU. Our study was not, 
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Fig. 1. Receiver operating characteristic curves for DU and MRA. Each point on curves 
represent particular sensitivity and specificity for identification of 60% to 99% carotid artery 
stenosis as determined by CA. 
however, designed to evaluate the screening charac- 
teristics of DU. We assumed that the referral of 
patients for further preoperative evaluation for ca- 
rotid endarterectomy and thus entrance into our 
study reflected relatively consistent lenient criteria 
within and between referring physicians. The DU 
results, however, were reevaluated with different 
criteria for use as a final preoperative t st. 
RESULTS 
Keceiver operating characteristic analysis 
With the prespecified cutoffcriteria for defining a 
positive test result, the area under the receiver 
operating characteristic curves were 0.95 for MRA 
and 0.91 for DU (Fig. 1). This difference was 
borderline significant at the 0.09 level. For each of the 
prespecified cutoff criteria for defining a positive test 
result, we calculated the sensitivity and specificity for 
identifying patients with 60% to 99% stenosis, as 
determined by CA (Table II). 
For the 16 possible cutoff criteria for the combi- 
nation strategy, we calculated the sensitivity and 
specificity conditional on DU and MRA being in 
agreement and the percentage of patients who 
undergo CA as a result of disparate results. The six 
criteria for the combination strategy that resulted 
in the lowest 5-year stroke risk are shown in Ta- 
ble II. 
Morbidity analysis 
Assuming that all patients with a positive test 
result undergo carotid endarterectomy, the expected 
S-year isk of stroke was 6.17% for MKA, 6.34% for 
the combination strategy, 6.35% for DU, and 7.12% 
for CA. The use of MRA in the preoperative 
evaluation of symptom-free patients with suspected 
carotid artery stenosis would result in approximately 
10 fewer strokes for every 1000 patients studied 
compared to evaluating these patients with CA, 
whereas the use of DU would result in approximately 
eight fewer strokes for every 1000 patients evaluated. 
The optimal positivity criterion for MRA was signal 
void or 50% to 99% stenosis; the optimal positivity 
criterion for DU was diminished velocity or peak 
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Table II. Sensitivities and specificities of the noninvasive t sting strategies for identifying patients 
with 60% to 99% angiographic stenosis 
Criteria for a positive test result Sensitiv#y (%) Specificity (%) 
DU: diminished velocity or peak systolic velocity of the internal carotid artery 
_> 150 cm/sec (DU150) ~ 
_> 200 cm/sec (DU200) 
_> 250 cm/sec (DU250) 
_> 300 cm/sec (DU300) 
MRA: signal void or percent stenosis 
50 to 99 (MRA50) ~ 
60 to 99 (MRA60) 
70 to 99 (MRA70) 
80 to 99 (MRA80) 
Combination strateg T (percent of patients who undergo contrast angiography 
because of disparate results)t 
DU200 and MRA50 (26%) ~ 
DU200 and MRA60 (24%) 
DU250 and MRA50 (31%) 
DU150 and MRA50 (26%) 
DU150 and MRA60 (31%) 
DU200 and MRA70 (25%) 
96.2 65.7 
90.4 82.8 
86.5 87.9 
67.3 90.9 
100.0 75.8 
96.2 80.8 
90.4 87.9 
67.3 94.9 
100.0 86.3 
97.9 88.0 
100.0 93.2 
100.0 77.6 
100.0 81.1 
95.7 92.7 
~Operating point associated with the least morbidity. 
?Sensitivity and specificity are conditional on DU and MRA results being in agreement (both positive or both negative). The top six (of 
I6) cutoff criteria are shown. 
systolic velocity of the internal carotid artery _> 150 
cm/sec (Table II). 
Sensifivity analysis 
Sensitivity analyses were performed varying (a) 
risk of stroke with CA (0% to 1.5%), (b) risk of 
stroke with carotid endarterectomy (1% to 5%), (c) 
sensitivity and specificity of noninvasive t sts (0.6 to 
1.0), (d) prevalence of 60% to 99% carotid artery 
stenosis (10% to 80%), and (e) long-term benefits 
from surgery for patients with 60% to 99% stenosis 
(0% to 100% reduction in risk after 30 days). 
CA was the least morbid of the four strategies 
only if the angiographic stroke risk was reduced to 
less than 0.04%; the combination strategy resulted in 
the least morbidity for angiographic stroke risks 
between 0.04% and 0.52%; MRA resulted in the 
least morbidity for angiographic stroke risks greater 
than 0.52% (Fig. 2). Results were not sensitive to the 
surgical risk, the prevalence of60% to 99% stenosis, 
or the long-term benefits from surgery in one-way 
sensitivity analyses. These variables became influen- 
tial only when the angiographic stroke risk was 
reduced to less than 0.13%. In a 3-way sensitivity 
analysis, we varied the sensitivity and specificity of an 
unspecified noninvasive test and the angiographic 
stroke risk (Fig. 3). Results were influenced more by 
the sensitivity and not the specificity of the noninva- 
sive test, as illustrated by the relatively flat lines in 
Fig. 3. If the angiographic stroke risk were as low as 
0.4% (top line in Fig. 3), then the choice betwcen CA 
and a noninvasive t st would depend largely on the 
sensitivity achievable for the noninvasive t st. 
The positivity criteria that resulted in the least 
morbidity for MRA and DU were influenced by the 
risk of stroke with carotid endarterectomy and the 
long-term benefits of surgery for pafients with 60% 
to 99% stenosis. As operative risk increases or the 
long-term benefit decreases, the optimal positivity 
criteria changes from one that is more lenient (i.e., 
higher sensitivity and lower specificity) to one that is 
more strict (i.e., lower sensitivity and higher speci- 
ficity). 
Although the MRA strategy was always superior 
to the DU strategy, the differences were minimal. 
Therefore, for centers that do not have adequate 
MRA, DU would be the optimal strategy for 
minimizing the risk of stroke as long as the angio- 
graphic stroke risk »vere greater than 0.38%. 
DISCUSSlON 
Recent results from ACAS have shown the 
importance of accurately idenfifying symptom-free 
patients with 60% to 99% carotid artery stenosis. 
Unfortunately, contrast angiography, the accepted 
gold standard for the preoperative d termination f 
carofid artery stenosis, isassociated with a significant 
risk of stroke. Although noninvasive imaging studies 
are appealing as a replacement for CA because oftheir 
lack of immediate risk, it is critical that sufticiently 
high accuracies be demonstrated for these tests. 
Inappropriate management resulting from false- 
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results in the lowest 5-year stroke risk is shown. Baseline result is indicated (x). 
negative or false-positive study results may offset any 
reduction in immediate morbidity that might be 
provided by a noninvasive test. Among the four basic 
preoperative valuation strategies considered in our 
analysis for symptom-free patients with suspected 
carotid artery stenosis, MRA was superior to the 
other three options in minimizing the 5-year risk of 
stroke. In centers where MRA is not available, DU is 
superior to CA. 
Our analysis was based largely on data from 
ACAS, and several presumptions must be made. 
First, our analysis assumes that all symptom-free 
patients with 60% to 99% carotid artery stenosis 
warrant surgical intervention. Second, in ACAS the 
angiographic stroke risk was high and the operative 
stroke risk was low compared with that reported by 
the Veterans Affairs Cooperative Study (VACS), 2a a 
study in which symptom-free patients with 50% to 
99% stenosis were randomized to receive either 
carotid endarterectomy or medical therapy. The 
angiographic stroke rate reported by VACS was 
0.4%, and the probability of stroke or death occur- 
ring during the perioperative period was 4.3%. 
Angiographic stroke risks among patients with symp- 
toms have been estimated as low as 0% and as high 
as 5.7%. 24 Thus we evaluated a wide range of stroke 
risks for both CA and carotid endarterectomy in
sensitivity analyses. Except for very low angiographic 
stroke risks (<0.04%),  noninvasive tests either 
individually or in combination were superior to CA 
alone. Varying the surgical stroke risk in a one-way 
sensitivity analysis never esulted in CA as the optimal 
alternative. With the VACS estimates in our analysis, 
the combination strategy resulted in the least morbid 
approach among the four proposed alternatives 
(Fig. 2). 
The operating characteristics for MRA and DU 
were obtained from one sample of patients. The 
advantage of using a single data set, as opposed to 
performing ametaanalysis of literature estimates, was 
that we were able to estimate sensitivities and 
specificities of the combination of MRA and DU 
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described by angiographic stroke risk (p), area bove line indicates region where noninvasive t st 
is optimal and area below line indicates region where contrast angiography is optimal. Four 
possible operating points considered for MRA (x) and DU (+) are shown. 
without assuming conditional independence given 
disease status for the two tests. The disadvantage was 
that our data reflect he experience of one institution. 
However, the sensitivities and specificities for MRA 
and DU achieved in our study are similar to those 
previously reported, 7-9,11,13 and we explored the 
effects of a wide range of test accuracies in sensitivity 
analyses. These analyses showed that even with use of 
0.4% as the angiographic stroke risk (VACS), a 
noninvasive test sensitivity of 0.93 and specificity of 
0.85 were adequate to allow this noninvasive test to 
be superior to CA (Fig. 3). 
Orten, decision analysis ehcidates tradeoffs that 
may not be readily apparent. In the CA strategy, all 
patients face an increased risk as a result of CA (1.2% 
per patient, ACAS). Mternatively, in a noninvasive 
test strategy, a few patients with false-positive r sults 
Face an increased risk because of carotid endarterec- 
tomy (1.5% per patient with a false-positive r sult, 
ACAS), and a few patients with false-negative r sults 
face an increased risk because of the missed benefits 
of surgery (7.6% per patient with a false-negative 
result,* ACAS). Thus for the 10% to 20% ofpatients 
with an inaccurate noninvasive test result, the addi- 
tional composite risk that they face is lower than the 
risk imposed on all patients by CA. The accuracy of 
DS can be quite variable as demonstrated by data 
derived from centers participating in ACAS. 25 Thus 
it may be appropriate for instimtions where the 
morbidity with CA is low and the accuracy with DS 
is poor to continue use of CA as the standard 
preoperative t st. This underscores the need for each 
instimtion to be aware of its accuracy for both 
tcchniques before determining the most appropriate 
preoperative t st for carotid endarterectomy. 
When choosing among tests or positivity criteria 
within a test, the option that yields the highest 
accuracy is not necessarily better. The accuracy of a 
test, which is a composite of the sensitivity and 
*Risk refers to the ensuing 5-year period, conditional on being 
stroke free at 30 days. 
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specificity, can be misleading. Therefore it is impor- 
tant to consider the relative consequences of a 
false-positive result versus a false-negative r sult. 26 In 
our baseline analysis, the DU cutoff that resulted in 
the highest accuracy differed from the cutoff that 
produced the lowest morbidity (the greatest accuracy 
resulted from a peak systolic velocity of the internal 
carotid artery of 250 cm/sec, and the least morbidity 
was found with a peak systolic velocity of 150 
cm/sec). For both MRA and DU, morbidity was 
reduced by use of noninvasive criteria that produced 
high sensitivities and low specificities. Paraphrased, it 
was better to have a false-positive result (and perform 
too many carotid endarterectomies with an added 
morbidity rate of 1.5% per patient) than to have a 
false-negative r sult (and allow patients with 60% to 
99% stenoses not to undergo carotid endarterectomy 
and face an added morbidity rate of 7.6% per 
patient). The optimal positivity criteria would favor 
lower sensitivities and higher specificities compared 
with those found in our analysis if the operative risk 
of stroke were to increase or if the long-term benefit 
of surgery were to decrease. The purpose of this 
analysis was to identify criteria for these noninvasive 
studies as preoperative tests. The criteria used when 
these same tests are used for screening patients for CA 
may be different. 
Mthough we found MRA alone to be superior to 
the other three strategies, there is little numeric 
difference between the long-term morbidity that 
follows the use ofMRA alone versus DU alone. This 
analysis has not taken into consideration the cost of 
these strategies, and it may be that the additional cost 
ofMRA versus DU outweighs the small advantage in 
morbidity that this test provides. Mthough the MRA 
techniques used in this study are readily transferable, 
many centers have not yet established the expertise 
that is necessary to achieve the accuracies that we 
report. Thus ifreasonable accuracies can be achieved, 
DU is a better alternative to CA. 
Our analysis suggests that, despite wide variations 
in our assumptions, MRA is associated with the 
lowest 5-year risk compared with DU, CA, and the 
combination of DU and MRA with CA for disparate 
results. Our results suggest that noninvasive tests 
should replace CA for the routine preoperative 
evaluation of patients with asymptomatic arotid 
artery disease. 
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DISCUSSION 
Dr. Morris D. Kerstein (Philadelphia, Pa.). Does 
angiography expose the patient to an additional risk of 
stroke, as a part of preparation for carotid endarterectomy? 
The answer is obviously es. 
Will the perioperative use o fMRA or DU reduce the 
risk? The literature suggests that MRA tends to overread; 
another issue is DU being performed by nonregistered or
inexperienced technicians. I am very interested in the 
accuracy of the laboratory and, more important, who 
measures it. 
I had the opportunity to call up a series ofhospitals that 
performed DU and asked if the technicians were registered 
vascular technicians (RVT). Of the 15 hospitals that I 
called, two had RVTs, the rest had technicians who had 
been retrained. When I asked who was supervising the 
studies, they said the Radiology Department. Did the 
radiologist have any unique, specific training looking at 
carotid artery disease? No, they had a history of being 
ultrasonographers. 
The literature suggests that the sensitivity and speci- 
ficity of MRA and DU are not significanfly different han 
the distinguishing surgical and nonsurgical degrees of 
stenosis. I think one has to separate the issue of MRA and 
DU and be careful one is not operating on the basis of DU 
results. I don't mean to question entirely the truth of my 
colleagues, but there is an issue of truth in reporting how 
many cases is enough that one should study for standards. 
What is your requirement for technician experience? 
Must they be registered? How many cases hould one do? 
How do we measure the quality of the equipment? 
Does the laboratory go through either quality assurance or 
utilization review? What is the minimal number of smdies 
required to be able to rely on DU? How does one regulate 
or quantitate MRA or duplex scanning? 
Do we need two tests or three? Does it apply to every 
institution? And if we do look at the real cost and do 
something besides DU, do the two tests add up to 
angiography? 
Dr. K. Craig Kent. An institution needs to have 
reasonably good sensitivity and specificity for noninvasive 
tests before they can be used to replace contrast angiogra- 
phy. If you're at an institution where these numbers can't 
be achieved, whether it be because of inadequacy of 
equipment or technical expertise, then neither DU not 
MRA should be used as preoperative t sts. If  you are at an 
institution where reasonably good accuracies can be 
achieved by noninvasive t sting, and this accuracy has been 
documented, then our analysis hows that either of these 
tests can be used as altematives to conventional angio- 
graphy. 
The issue about what department manages the vas- 
cular laboratory is relevant only in that this supervision 
may contribute to the accuracy of these tests. It is our 
belief that reasonably good accuracies with DU can and 
should be consistently achieved by certified laboratories. 
If you review the literature, there area  number of 
institutions that äre reporting accuracies for DU in the 
range of 85% to 95%. In our analysis we can clearly show 
that, with an accuracy of that level, it is rar bettet o use 
DU as the preoperative t st than CA, when the end point 
is long-term morbidity. 
However, we fully agree with your point that vascular 
laboratories should be monitored and their quality stan- 
dardized. 
Dr. Robert P. Leather (Mbany, N.Y.). Duplex studies 
are very operator-dependent. Themachines are bought by 
many radiology departments for one reason- to  make 
money. The people that run them frequently aren't rained, 
and you can tell that from reading the report. Each duplex 
operator must have a proven track record as compared to 
conventional ngiography, even with its limitations. And 
this has been a recurrent problem. In New York I've 
reviewed several cases where they have said they have a very 
good laboratory with no demonstration f accuracy. That's 
what you're preaching against. This is a very important 
aspect of the whole thing. 
Dr. Kent. Beyond guaranteeing that your laboratory is
of good quality, it is necessary that the criteria for 
determining a particular degree of stenosis be individual- 
ized for each laboratory. As part ofthis study, we combined 
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data from DU from Brigham and Women's and Beth Israel 
Hospitals, and what we found was that the cutoffpoint that 
provided the best accuracy for Brigham was not the same 
as the cutoffpoint that provided the best accuracy for Beth 
Israel. So even ifyou have a good vascular technologist and 
equipment, you still have to examine and understand the 
criteria for determining a particular degree of stenosis that 
works best for your laboratory. 
Dr. Keith D. Calligaro (Philadelphia, Pa.). Our 
Section of Vascular Surgery is not recommending surgery 
for people with asymptomatic 60% to 70%. I find it very 
hard to believe that there was not a significant benefit of 
surgery for asymptomatic 90% to 99% stenosis, a big 
benefit for 80% to 90%, maybe a benefit for 70% to 80%, 
and prohably no benefit for 60% to 70%. And the reason 
I feel that way is the overall benefit ofsurgery was only 10% 
compared to 5% for aspirin. Therefore 90% ofpatients, if
you don't do anything, are going to be fine over 5 years. 
I don't think we should be strongly urging that patients 
with less than 70% to 80% stenosis be recommended for 
surgery. 
Dr. Kent. You have hrought up a very important 
point. When creating a decision analysis model, a number 
of assumptions need to be made. The overall assumption 
that we have made is that operating on a greater than 60% 
stenosis, in a symptom-free patient, is the correct hing to 
do. Now this may not be the right thing to do, and, after 
critical analysis of the ACAS study, each of us will 
individually need to make our own decision. If it's 
eventually proven that an 80% cutoff is appropriate, then 
we need to redo the analysis for this cutoff. The reason we 
didn't do this analysis for an 80% cutoff is because the 
long-term follow-up data are not available for treatment of 
a greater than 80% stenosis, whereas follow-up data are 
available for treatment of a 60% stenosis because of ACAS. 
Dr. Robert  E. Madden (Valhalla, N.Y.). There is 
other use~ll information to be obtained from an angiogram 
that cannot be done otherwise, and that is the level of the 
bifurcation, the length of the lesion, the possibility of 
seeing an ulcer, and the presence or absence of an adequate 
anterior communicating circle of Willis. So this is addi- 
tional useful preoperative information. 
Dr. Kent. The real question you have to ask yourself 
is, do you need to know any of this information'before 
taking a patient for carotid endarterectomy? The most 
current studies don't use ulceration as a criteria for carotid 
endarterectomy. I seldom find that the presence or absence 
of ulceration influences my decision about operation. 
Significant intracranial stenoses are rare, and a number of 
studies recommend endarterectomy of an extracranial 
lesion even when a tandem high-grade intracranial stenosis 
exists. You have to ask yourself how orten have you 
changed your mind about doing an endarterectomy on the 
basis of length of the lesion or the level of the carotid 
bifurcation. In my own practice, this would be a rare 
occurrence. 
However, if, for a particular surgeon's practice, it is 
necessary to know the level of the carotid bifurcation or 
whether an ulceration or intracranial stenosis is present, 
then contrast angiography will always be necessary. We 
have examined the ability for MRA to define intracranial 
stenoses and ulceration, and the results have been disap- 
pointing. 
Dr. Jeffrey P. Carpenter (Philadelphia, Pa.). In my 
view, both duplex scanning and MRA are rather poor for 
detecting arch lesions. Would you say a few words about 
that? 
Also, I didn't quite understand whether you're advo- 
cating that we use both DU and MRA or one or the other. 
And, finally, did you plug the dollar amounts into that 
decision analysis? 
Dr. Keilt. To answer your first question, you can ger 
information, as you know, from MRA about the arch. 
However, once again, Fm not sure that this information is
necessary in all patients. Studies have shown that if you 
don't feel a diminished common carotid artery pulse or 
have a difference in the blood pressure between arms, the 
chance of having an arch lesion is exceedingly small and 
probably not large enough to warrant even doing routine 
CA of the arch if you still consider this your preferred 
technique. 
In terms of your question about cost, yes we did do a 
cost-effectiveness analysis. To operate on a symptom-free 
patient with a greater than 60% stenosis, we found the cost 
per quality-adjusted life-year to be $139,000, which is a 
very large amount o pay for any medical intervention, so, 
in fact, carotid endarterectomy ay not be cost-effective in 
these patients. Because of this, it was impossible to 
determine the cost-effectiveness of preoperative t sts. 
With regard to your last question about whether we 
recommended both tests or an individual test, it is pretty 
clear from our data, becanse the numbers are so close, that 
you can use either MRA or DU, and either alone is 
sufficient. So, if it turns out at your institution that you 
don't have good results from MRA, but your DU achieves 
good accuracy, ou should use DU, and vice versa, i fMRA 
is better. 
Dr. Enrico Ascer (Brooklyn, N.Y.). Our results with 
the combined approach of DU and MRA are certainly 
better. There are some cases of vessel tortuosity in which 
there is no significant stenosis where high peak systolic 
velocities are obtained. It's always good at this stage to have 
another test that's also noninvasive. 
Out results with 100 consecutive cases with this 
approach ave been okay. Our accuracy rate of detection of 
the lesion was 94% before we started this study, so we feel 
comfortable doing it. The results of 5% or 6% of the cases 
would be in doubt, and rather than doing those unneces- 
sary endarterectomies to cover the data, we think that 
maybe MRA are helpful. 
Dr. Kent. We did this same analysis on a hypothetical 
cohort of patients with greater than 70% stenosis, and we 
came to a conclusion similar to yours, that the combination 
of MRA and DU is much more cost-effective than either 
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of the tests individually. Ironically, we actually ended up 
with the same accuracy that you did, 94%, with a sensitivity 
of 100%, and a specificity of 88%. For symptomatic pa- 
tients who have greater than 70% stenosis, we recommend 
that both tests be performed, with contrast angiography 
reserved for instances when these test results disagree. 
However, when we did this same analysis in a 
hypothetical cohort of symptom-free patients with greater 
than 60% stenosis, it was not advantageous to combine 
both tests. The morbidity rate was similar for MRA alone, 
DU alone, or MRA and DU. However, clearly in the 
symptomatic group, the analysis was completely different, 
and combining data from both tests works very well for us, 
just as it has for you. 
Dr. Robert W. Hobson I I  (Newark, N.J.). I am 
trying to learn more about decision analysis. Intuitively, I 
think your conclusions are laudable, and we should move 
away from angiography. Even in the VA trial on asymp- 
tomatic carotid artery stenosis with its 0.4% stroke risk, 
eliminating these risks will improve results. 
However, I am concerned that decision analysis results 
in the suggestion that performance of% few more carotid 
endarterectomies" becomes acceptable. I don't hink such a 
conclusion is realistic. Data from the ACAS trial suggest 
that performance of19 carotid endarterectomies to prevent 
one stroke is acceptable. However, its cost-effectiveness is 
being challenged by Matchar and others. Use of a statistical 
method that results in ever larger numbers of procedures 
will be difficult to justify, even in an effort to exclude the 
risk of angiography. 
Recognizing that only about 20% of the patients in the 
VA or ACAS trials with those 80% to 60% stenoses have 
development of symptoms during a S-year follow-up, we 
should be performing subset analyses. Factors such as 
plaque structure, analysis of collateral cerebral circulation, 
the incidence of silent, computed tomography-confirmed 
infarctions, and associated risk factor analyses are suggested 
topics. 
Have you reviewed your classification of plaque struc- 
ture? Although percentage stenosis is our current indicator 
of risk, I predict hat some day it's going to be considered 
as only a fair predictor of neurologic events. Plaque 
structure and other factors will be equally or more 
important. Do you have data on plaque structure or other 
subset analyses that you can share? 
Dr. Kent. With MRA we initially examined plaque 
structure in hopes of finding an association between 
symptoms and plaque configuration or composition. So 
far, we have not been able to prove an association. MRA 
turns out to be a poor test in terms of defining ulceration 
or plaque irregularity. 
Adjusting sensitivity of noninvasive tests so that we 
perform "too many" carotid endarterectomies, rather than 
miss patients who would benefit from surgery makes both 
logical and statistical sense if we firmly believe there is an 
advantage for operation on symptom-free patients with 
greater than 60% stenosis. Performing a carotid endarter- 
ectomy unnecessarily results in a 1.5% chance of stroke, 
whereas missing a high-grade stenosis in a patient who 
would benefit from carotid endarterectomy results in a 
greater than 70% chance of stroke. If a subset analysis 
shows that we should operate on higher grade lesions, with 
greater benefit, this would provide even more support o 
the premise that it is better to perform a carotid endarter- 
ectomy with its morbidity than to miss a significant lesion 
and expose apatient o a much higher isk of stroke because 
an operation is not performed. 
